Skip to main content
. 2015 May 7;13:140. doi: 10.1186/s12967-015-0501-5

Figure 3.

Figure 3

Median overall survival (OS) results. Kaplan-Meier curves for median OS of colorectal cancer patients treated with irinotecan and cetuximab prospectively allocated in the unfavourable (-------) and favourable (———) arm (6 months vs. 15 months, p < 0.0001).